Tamarack Advisers’s Bioventus BVS Stock Holding History

Tamarack Advisers’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-750,001	Closed	-$5.25M	–	39
2022 Q3	$5.25M	Hold	750,001	–	–	3.08%	15
2022 Q2	$5.12M	Sell	750,001 -75,000	-9%	-$765K	2.96%	16
2022 Q1	$11.6M	Sell	825,001 -49,999	-6%	-$669K	5.5%	5
2021 Q4	$12.7M	Buy	875,000 +395,000	+82%	+$5.62M	5.21%	4
2021 Q3	$6.8M	Buy	480,000 +5,000	+1%	+$76.9K	2.15%	21
2021 Q2	$8.36M	Sell	475,000 -200,000	-30%	-$3.22M	2.37%	15
2021 Q1	$10.3M	Buy	+675,000	New	+$9.61M	2.12%	19

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Tamarack Advisers's BVS Position: Q4 2022 in Review

Tamarack Advisers sold out of Bioventus (BVS) in Q4 2022, closing a stake of 750,001 shares — an estimated $5.25M sold.

Tamarack Advisers first reported a position in BVS in Q1 2021 and held it in 7 quarters. The position peaked at $12.7M in Q4 2021. 85 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

Tamarack Advisers reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
Tamarack Advisers sold 750,001 Bioventus shares in Q4 2022, an estimated $5.25M.
Tamarack Advisers first reported a position in Bioventus in Q1 2021 and held it in 7 quarters.
Tamarack Advisers's Bioventus position peaked at $12.7M in Q4 2021.
85 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Tamarack Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.